PHARMACOLOGY
Guidelines from the French Society of Pharmacology and Therapeutics (SFPT) and the ANRS-MIE AC43 Pharmacologic group for the Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19
This guidelines are available at https://sfpt-fr.org/recospaxlovid
Related publication: Lemaitre F et al. Therapie. 2022 Apr 20:S0040-5957(22)00065-8.
doi: 10.1016/j.therap.2022.03.005. Online ahead of print. PMID: 35618549
Coordinators : Florian Lemaitre, Elisabeth Polard (Rennes)
Writers : Stéphane Bouchet (Bordeaux), Matthieu Grégoire (Nantes), Florian Lemaitre (Rennes), Caroline Monchaud (Limoges), Elisabeth Polard (Rennes), Béatrice Saint-Salvi (St Denis)
Reviewers : Sihem Benaboud (Paris), Laurent Chouchana (Paris), Jean-Luc Cracowski (Grenoble), Milou-Daniel Drici (Nice), Rodolphe Garraffo (Nice), Annie-Pierre Jonville-Bera (Tours), Mathieu Molimard (Bordeaux), Patrice Muret (Besançon), Gilles Peytavin (Paris), Vincent Richard (Rouen), Caroline Solas (Marseille)
DOWNLOAD
DDI Paxlovid Therapie 2022